arrow
Y

Yong Yi

fudan university
H指数:29
被引数:2,522

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study

替雷利珠单抗联合仑伐替尼和GEMOX方案治疗不可切除的局部晚期胆道癌的转化治疗(ZSAB-TransGOLP):一项多中心、前瞻性、Ⅱ期研究

2025-08-290
PRE
First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study

一线tislelizumab和ociperlimab联合吉西他滨和顺铂治疗晚期胆道癌 (zsab-top): 一项多中心,单臂,2期研究

2025-08-210
OAAI
Single-cell and spatial architecture of primary liver cancer
2023-11-2011
OAAI
Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: a multicenter retrospective study
2019-12-127
OAAI